![]() |
Name |
2,6-Dimethoxyterephthalic acid
|
Molecular Formula | C10H10O6 | |
IUPAC Name* |
2,6-dimethoxyterephthalic acid
|
|
SMILES |
COC1=CC(=CC(=C1C(=O)O)OC)C(=O)O
|
|
InChI |
InChI=1S/C10H10O6/c1-15-6-3-5(9(11)12)4-7(16-2)8(6)10(13)14/h3-4H,1-2H3,(H,11,12)(H,13,14)
|
|
InChIKey |
XZZNMOQLQQVIFN-UHFFFAOYSA-N
|
|
Synonyms |
2,6-Dimethoxyterephthalic acid; 16849-69-7; 2,6-dimethoxy terephthalic acid; EINECS 240-872-1; SCHEMBL9515990; DTXSID80168571; 2,6-Dimethoxy-1,4-benzenedicarboxylic acid
|
|
CAS | 16849-69-7 | |
PubChem CID | 85613 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Molecular Weight: | 226.18 | ALogp: | 0.9 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 93.1 | Aromatic Rings: | 1 |
Heavy Atoms: | 16 | QED Weighted: | 0.808 |
Caco-2 Permeability: | -5.83 | MDCK Permeability: | 0.00001080 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.256 | 20% Bioavailability (F20%): | 0.564 |
30% Bioavailability (F30%): | 0.74 |
Blood-Brain-Barrier Penetration (BBB): | 0.283 | Plasma Protein Binding (PPB): | 31.00% |
Volume Distribution (VD): | 0.279 | Fu: | 58.25% |
CYP1A2-inhibitor: | 0.022 | CYP1A2-substrate: | 0.734 |
CYP2C19-inhibitor: | 0.03 | CYP2C19-substrate: | 0.042 |
CYP2C9-inhibitor: | 0.053 | CYP2C9-substrate: | 0.06 |
CYP2D6-inhibitor: | 0.02 | CYP2D6-substrate: | 0.071 |
CYP3A4-inhibitor: | 0.028 | CYP3A4-substrate: | 0.025 |
Clearance (CL): | 3.318 | Half-life (T1/2): | 0.918 |
hERG Blockers: | 0.047 | Human Hepatotoxicity (H-HT): | 0.234 |
Drug-inuced Liver Injury (DILI): | 0.93 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.07 | Maximum Recommended Daily Dose: | 0.005 |
Skin Sensitization: | 0.085 | Carcinogencity: | 0.01 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.945 |
Respiratory Toxicity: | 0.058 |